Lateral flow assays are immunoassay technology used for point-of-care testing to detect the presence or absence of target analytes in samples like urine, blood and saliva. It enables quick diagnosis with results available in minutes. Rising cases of infectious diseases and growing need for point-of-care testing can boost demand for lateral flow assays globally. Moreover, home based lateral flow test kits for conditions like pregnancy, glucose monitoring and COVID are witnessing huge adoption. However, regulations associated with product approval can hamper the market growth during the forecast period.
Market Dynamics:
Global lateral flow assay market growth is driven by factors like rising cases of infectious diseases like HIV, tuberculosis, and influenza which necessitates early diagnosis. Growing geriatric population susceptible to chronic diseases can also boost demand for these assays. Rising demand for point-of-care testing enabled by lateral flow assays, which provides results within minutes, can drive the market growth. Rising sales of home based test kits can offer market growth opportunities. However, factors like stringent regulatory framework and lengthy product approval process can hamper the market growth. High cost of advanced lateral flow assays can also hamper the market growth. Technological advancements to enhance accuracy and reproducibility can offer growth opportunities.
Key Features of the Study:
- This report provides in-depth analysis of the global lateral flow assay market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global lateral flow assay market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott, F. Hoffmann-La Roche Ltd, Danaher, Siemens, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, PerkinElmer Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global lateral flow assay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lateral flow assay market
Detailed Segmentation-
Detailed Segmentation-
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients